Real-world disparities between patient- and clinician-reported outcomes: results from a disease-specific program in depression and anxiety.

Prof Case Manag

Shannon Lubaczewski's, PharmD, MS, 15-year career in the pharmaceutical industry includes diverse experiences such as drug manufacturing and packaging, project management, vendor management, clinical quality auditing, pharmacovigilance auditing, clinical pharmacy, and clinical study management from initial planning through coauthoring of the clinical manuscript. Shannon earned a bachelors degree in pharmacy at the Philadelphia College of Pharmacy and Science. She completed a master's degree in quality assurance and regulatory affairs from Temple University. She also earned a doctorate in pharmacy from the University of the Sciences in Philadelphia. She maintains licensure in the state of Pennsylvania. Jason Shepherd, Project Director, Adelphi Real World, joined Adelphi in 2001 after previous marketing research roles with the Medical Research Council, The Research Business International, and NOP in London. He has worked across many therapy areas and is currently responsible for the Neuroses Disease-Specific Programme for Adelphi Real World. Rana Fayyad, PhD, is a statistician with 20 years in the Pharmaceutical industry. Rana has been an employee of Pfizer Inc. for 14 years and, during her career, worked on multiple therapeutic areas, including cardiovascular, oncology, neuroscience, and ophthalmology, covering phases II-IV, as well as publications, and regulatory responses. Rana obtained her PhD in statistics from Colorado State University. Christine J. Guico-Pabia, MD, MBA, MPH, is a physician executive with diverse health care management experience in pharmaceutical, managed care, public health, and medical delivery environments. Christine has a sustained track record of effectively developing and launching innovative pharmaceutical, medical informatics, and managed care products with particular expertise in neuroscience and women's health. She joined Wyeth Pharmaceuticals, now Pfizer Inc., more than 6 years ago as Director and later as Senior Director, Global Med

Published: April 2015

Purpose: The purpose of this study was to identify potential discordance between physician and patient rated measures of depression used by primary care physicians and psychiatrists.

Primary Practice Setting: This study collected data from primary care physicians and psychiatrists in the United States between October and December 2009.

Methodology And Sample: A real-world, cross-sectional study was conducted using the Neuroses Disease-Specific Programme (Adelphi Real World, Macclesfield, United Kingdom). Treatment practice data were collected by 180 physicians (100 primary care and 80 psychiatrists) who were asked to provide information for the next 15 outpatients presenting prospectively with symptoms of anxiety and/or depression (n = 2,704 patients). The primary outcome measures were the Clinical Global Impressions-and Patient Global Impressions-Improvement scales, completed by both physicians and their matched patients, respectively. Cohen's kappa coefficient (κ) was calculated to assess the level of agreement between the Clinical Global Impressions-and Patient Global Impressions-Improvement scale responses.

Results: Physician- and patient-rated overall improvement in illness was 82% and 89%, respectively. Results of the kappa analysis demonstrated fair agreement between patients and physicians regarding overall improvement in illness (44% agreement; κ= 0.23). Physician ratings of patient improvement progressively decreased with increased severity of illness.

Implications For Case Management Practice: These real-world data suggest that the degree of reduction in symptoms of anxiety and/or depression may be estimated differently by physicians when compared with their patients. Understanding the potential for disparities between physician- and patient-rated measures in reviewing patient care, particularly in patients with more severe depressive symptoms, can help ensure that treatment plans are aligned with patient needs.

Download full-text PDF

Source
http://dx.doi.org/10.1097/NCM.0000000000000015DOI Listing

Publication Analysis

Top Keywords

primary care
12
care physicians
8
symptoms anxiety
8
anxiety and/or
8
and/or depression
8
clinical global
8
global impressions-and
8
impressions-and patient
8
patient global
8
global impressions-improvement
8

Similar Publications

Patient centered medication treatment for opioid use disorder in rural Vermont: a qualitative study.

Addict Sci Clin Pract

January 2025

Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, NH, 03766, USA.

Background: Opioid-related fatal overdoses are occurring at historically high levels and increasing each year. Accessible social and financial support are imperative to the initiation and success of treatment for Opioid Use Disorder (OUD). Medications for Opioid Use Disorder (MOUD) offer effective treatment but there are many more people with untreated OUD than receiving evidence-based medication.

View Article and Find Full Text PDF

Background: Sepsis-associated encephalopathy (SAE) may be worsened by early systemic insults. We aimed to investigate the association of early systemic insults with outcomes of critically ill patients with severe SAE.

Methods: We performed a retrospective analysis using data from the French OUTCOMEREA prospective multicenter database.

View Article and Find Full Text PDF

Background: Blinding is essential for mitigating biases in trials of low back pain (LBP). Our main objectives were to assess the feasibility of blinding: (1) participants randomly allocated to active or placebo spinal manual therapy (SMT), and (2) outcome assessors. We also explored blinding by levels of SMT lifetime experience and recent LBP, and factors contributing to beliefs about the assigned intervention.

View Article and Find Full Text PDF

Background: Perinatal growth and nutrition have been shown to be determinants in the programming of different tissues, such as adipose tissue, predisposing individuals to metabolic alterations later in life. Previous studies have documented an increased risk of metabolic disturbances and low-grade inflammation in prepubertal children with a history of extrauterine growth restriction (EUGR). The aim of this study was to evaluate possible alterations resulting from impaired growth during early childhood and their impact on young adult health.

View Article and Find Full Text PDF

Use of virtual reality to remotely train healthcare professionals in paediatric emergency tracheostomy skills: protocol for a multi-centre, non-inferiority educational interventional study with historical controls.

BMC Surg

January 2025

Division of Immunology, Immunity to Infection, and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.

Background: The insertion of a tracheostomy is an established technique used to wean patients off ventilatory support, manage secretions in complex conditions, and as a potentially life-saving procedure to bypass upper airway obstruction. Life-threatening complications during aftercare are not uncommon and may be influenced by a lack of education of carers or healthcare providers of children and young people living with a tracheostomy. Education programmes designed and supported by the National Tracheostomy Safety Project are effective, but resources are not available to educate the workforce at scale.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!